81
30
Growth Score
-5 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2180793
Medigen Biotechnology focuses on the development of new products in the two major areas of “hepatopathy” and “cancer” in Asia.
- Stanley Chang: CEO & Chairman
About the Company
Medigen Biotechnology was established at the end of 1999. The company adheres to the vision of “Innovation makes life better” and focuses on the development of new products in the two major areas of “hepatopathy” and “cancer” in Asia. Through years of hard work, Keya Biotech has gradually developed into a comprehensive biopharmaceutical group, and
its business has covered: new drug clinical development, innovative biomedical research and development platform, molecular detection, cell culture vaccine technology, and scientific name drug production and marketing. And many other businesses.
